These biotech stocks are getting hammered by shocking brittle-bone
treatment study results
-
Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs
after disappointing trial results for setrusumab.
1 hour ago





AT ALL COST, CONSTRUCT or DESTRUCT in deed is THE PRICE TO PAY ; .... Greenwald Destroys MSNBC's Attempted Propaganda: http://youtu.be/BJyp6_4P_6Y via @youtube
ReplyDelete